Noble Medical, Inc. is a global leader in on-site drug of abuse testing products, offering a range of solutions under trade names such as Insta-Screen Cup, Split-Specimen Cup, and One Step Cup. With a founding date of 1997, the company has continuously integrated cutting-edge technologies to enhance testing efficiencies and customer satisfaction over its 20-year history. Renowned for its product quality, commitment to exceptional service, and experienced staff, Noble Medical has established itself as a trusted name in the industry. The company's sister entity, Noble Diagnostics, specializes in providing administrative services and consulting for both US Department of Transportation (DOT) and Non-DOT drug and alcohol testing programs, acting as a TPA and MRO and tailoring testing programs and policies to individual client needs. The company's dedication to ensuring drug-free workplaces and commitment to industry-leading standards make it an attractive investment prospect for venture capitalists seeking to support innovative solutions that address critical social and business needs. With the potential to further expand its reach and impact, Noble Medical, Inc. presents an exciting opportunity for investment in the healthcare technology sector.
There is no investment information
No recent news or press coverage available for Noble Medical, Inc..